BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38733176)

  • 1. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
    Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.
    Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T
    J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Uno K; Koike T; Kusaka G; Takahashi Y; Ara N; Shimosegawa T
    Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
    Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502.
    Mitani S; Kato K; Daiko H; Ito Y; Nozaki I; Kojima T; Yano M; Nakagawa S; Ueno M; Watanabe M; Tsunoda S; Abe T; Kadowaki S; Kadota T; Sasaki K; Machida R; Kitagawa Y
    J Gastroenterol; 2022 Jul; 57(7):455-463. PubMed ID: 35546373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
    Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
    Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in elderly patients: a single-center retrospective cohort study.
    Ishido K; Tanabe S; Katada C; Kubota Y; Furue Y; Wada T; Watanabe A; Koizumi W
    Jpn J Clin Oncol; 2021 May; 51(6):895-904. PubMed ID: 33738500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blue laser imaging identifies endoscopic findings corresponding to metachronous esophageal squamous cell carcinoma.
    Azuma Y; Dohi O; Naito Y; Yasuda T; Yoshida T; Ishida T; Kitae H; Matsumura S; Doi T; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Takagi T; Ishikawa T; Konishi H; Nishimura A; Kishimoto M; Itoh Y
    Esophagus; 2022 Apr; 19(2):278-286. PubMed ID: 34773554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell cancer in patients with prior gastrectomy.
    Xu JQ; Hu JW; Chen WF; Xu MD; Zhong YS; Chen SY; Zhang YQ; Ma LL; Qin WZ; Cai MY; Yao LQ; Zhou PH; Li QL
    Surg Endosc; 2021 May; 35(5):2229-2239. PubMed ID: 32430528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic submucosal dissection for early esophageal squamous cell carcinoma: long-term results from a Western cohort.
    Beaufort IN; Frederiks CN; Overwater A; Brosens LAA; Koch AD; Pouw RE; Bergman JJGHM; Weusten BLAM
    Endoscopy; 2024 May; 56(5):325-333. PubMed ID: 38325394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metachronous carcinogenesis of superficial esophagus squamous cell carcinoma after endoscopic submucosal dissection: incidence and risk stratification during long-term observation.
    Ogasawara N; Kikuchi D; Inoshita N; Nakayama A; Kohno K; Ochiai Y; Hayasaka J; Suzuki Y; Dan N; Okamura T; Mitsunaga Y; Tanaka M; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S; Iizuka T
    Esophagus; 2021 Oct; 18(4):806-816. PubMed ID: 33974189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.
    Fukuhara T; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
    J Clin Gastroenterol; 2010 Feb; 44(2):e27-33. PubMed ID: 19730116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Kim GH; Min YW; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
    PLoS One; 2020; 15(9):e0238113. PubMed ID: 32886924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
    Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
    World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of endoscopic submucosal dissection for early oesophageal squamous cell neoplasia at a Western centre.
    Lorenzo D; Barret M; Leblanc S; Terris B; Beuvon F; Coriat R; Chaussade S; Prat F
    United European Gastroenterol J; 2019 Oct; 7(8):1084-1092. PubMed ID: 31662865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in Taiwan.
    Hsu MH; Wang WL; Chen TH; Tai CM; Wang HP; Lee CT
    BMC Gastroenterol; 2021 Aug; 21(1):308. PubMed ID: 34344303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma: a propensity score matching analysis.
    Huang R; Cai H; Zhao X; Lu X; Liu M; Lv W; Liu Z; Wu K; Han Y
    Gastrointest Endosc; 2017 Nov; 86(5):831-838. PubMed ID: 28286094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic submucosal dissection under general anesthesia for superficial esophageal squamous cell carcinoma is associated with better clinical outcomes.
    Song BG; Min YW; Cha RR; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
    BMC Gastroenterol; 2018 Jun; 18(1):80. PubMed ID: 29879909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The five-year survival rate after endoscopic submucosal dissection for superficial esophageal squamous cell neoplasia.
    Nagami Y; Ominami M; Shiba M; Minamino H; Fukunaga S; Kameda N; Sugimori S; Machida H; Tanigawa T; Yamagami H; Watanabe T; Tominaga K; Fujiwara Y; Arakawa T
    Dig Liver Dis; 2017 Apr; 49(4):427-433. PubMed ID: 28096057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognosis after endoscopic submucosal dissection for esophageal cancer in older adult patients.
    Konishi H; Urabe Y; Nakamura T; Ishibashi K; Mizuno J; Fukuhara M; Takasago T; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Ishikawa A; Oka S
    BMC Gastroenterol; 2024 May; 24(1):164. PubMed ID: 38745162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.